Agilent Technologies Inc
Global leader in analytical instruments, software, services, and consumables for laboratories across life sciences, diagnostics, and applied chemical markets
What the page says before deeper research
Quality, growth, value, ownership, risk, and source confidence.
Moat 9.2/100 with low retention risk and high switching costs.
Growth appears mixed from +8.1% YoY revenue growth.
Forward P/E of 18.3x versus +8.1% growth gives a 2.2x multiple-to-growth read.
No SEC-backed 13F layer is matched yet, so ownership confirmation is unavailable.
Retention and AI disruption risks are low; valuation is not flagged expensive.
Fundamentals from finnhub as of 2026-05-17; ownership confirmation is not available here.
Revenue growth tells beginners whether the business is expanding before valuation gets complicated.
Beginner valuation check
Data pending from FMP or Finnhub.
Negative price performance shows recent market sentiment, not a full investment thesis.
Forward P/E around 18.3x means investors pay about $18.3 for each expected $1 of future profit per share, usually the next 12 months or next fiscal year. It is a forecast, not a fact.
A P/E around 24.5x means investors pay about $24.5 for each $1 the company earned per share over the last 12 months, usually the last four quarterly reports.
Source: market data index. As of May 21, 2026. P/E can be unavailable or misleading when earnings are negative.
Beginner guide
Agilent Technologies Inc makes technology that helps scientists and doctors do their work more accurately.
Global leader in analytical instruments, software, services, and consumables for laboratories across life sciences, diagnostics, and applied chemical markets
Agilent Technologies Inc makes money through Laboratory Operations, Analytical Sciences, Field Service, and Quality Assurance.
Mission-critical instruments with 15-20 year lifecycles create sticky recurring service revenue
Agilent Technologies Inc can disappoint if execution, competition, valuation, or demand cycles weaken growth, margins, customer retention, or investor confidence.
Agilent Technologies Inc is like part of the healthcare toolkit: patients, providers, or researchers rely on it when quality and trust matter.
You are basically betting that Agilent Technologies Inc can keep turning laboratory operations into durable value while managing execution, competition, valuation, or demand cycles.
A 0-100 shortcut for how defensible the business looks in this company brief. Agilent Technologies Inc is scored at 9.2.
How painful it is for customers to leave. this company brief rates Agilent Technologies Inc as high.
Whether existing customers tend to spend more or less over time. The company brief model uses 108%.
The main pieces of the company here are Laboratory Operations, Analytical Sciences, Field Service, and Quality Assurance.
Price divided by earnings. It is a quick valuation check, but it can mislead when earnings are temporarily high, low, or negative.
A quarterly filing that shows what many large institutional investors owned at quarter end.
The first four questions
Mission-critical analytical instruments, software, services, and consumables can support sticky recurring service and consumables demand across long customer lifecycles.
Agilent can disappoint if demand, competition, or execution weakens growth, customer retention, or confidence in its lab platform economics.
Forward P/E (18.3x)
Next earnings date unavailable from configured sources.
Bull / Neutral / Bear
Agilent keeps converting its installed base into steady laboratory workflow value while investors focus on how the current forward multiple compares with growth.
Forward P/E around 18.3x remains reasonable versus growth.
Laboratory Operations stays durable and recurring service/consumables demand remains anchored by mission-critical customer workflows.
Revenue growth stays positive near +8.1% or improves.
Agilent keeps converting its installed base into steady laboratory workflow value while investors focus on how the current forward multiple compares with growth.
Forward P/E around 18.3x remains reasonable versus growth.
The setup weakens if lab spending slows, competitive pressure rises, or execution falters and the market re-rates the shares lower.
Revenue growth slows and demand or competitive pressure becomes more visible.
Beginner checklist
Needs earnings calendar data from a provider.
Revenue growth tells beginners whether the business is expanding before valuation gets complicated.
Margin trend needs company financial statement data; do not infer it from price movement.
Forward P/E is a quick valuation anchor, but it must be compared with growth and business quality.
No SEC-backed ownership rows are available for this ticker yet.
Needs insider transaction data from a provider.
For Agilent, track whether laboratory operations is strengthening or softening across its installed base and workflows.
Agilent Technologies Inc is exposure to healthcare technology operating model with high switching costs and 108% net revenue retention.
Mission-critical instruments with 15-20 year lifecycles create sticky recurring service revenue
The main question is whether the company can keep customer value compounding without margin pressure eroding the moat.
Pro access unlocks the workflow simulator for this company brief.
Simulator coverage pending
This ticker has a company brief, but richer workflow modules have not been built yet.
No SEC-backed 13F rows are matched for this ticker yet. We do not fabricate ownership rows.
- Mission-critical instruments with 15-20 year lifecycles create sticky recurring service revenue
- Proprietary consumables (columns, reagents) generate 40%+ gross margins with automatic reordering
- Validated analytical methods require months/years to transfer to competitor platforms
- Regulatory compliance (FDA, EPA) creates switching friction - customers avoid revalidation costs
- Deep scientific expertise and Ph.D. field support impossible for new entrants to replicate
- AI enhances rather than replaces - improves method optimization and data analysis workflows